Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baohui Han

Showing results (31-40 of 426) with videos related to

Pageof 43
Sort By:
International Journal of Clinical and Experimental Pathology|January 23, 2020
Accuracy and clinical influence of plasma EGFR mutation detection in management of advanced lung adenocarcinomaMeili Ma, Chunlei Shi, Jialin Qian, et al.
Thoracic Cancer|September 19, 2017
Lung cancer and benign lung diseases in patients with serious vitamin D deficiency in eastern ChinaRong Li, Jing Wu, Liwen Xiong, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 21, 2025
[Expert Consensus on Diagnosis and Treatment of NSCLC with MET Abnormalities 
(2025 Version)]Jun Chen, Baohui Han, Yi Hu, et al.
Oncotargets and Therapy|April 27, 2018
Efficacy of pemetrexed-based regimens in advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic reviewBaoHui Han, LuLu Yang, Xin Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 8, 2014
MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancerJun Pei, Yuqing Lou, Runbo Zhong, et al.
Journal of Comparative Effectiveness Research|December 17, 2024
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from ChinaHua Zhong, Jun Lu, Mengzhao Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 20, 2010
[The clinical analysis of first-line palitaxel plus platinum-based chemotherapy to treat elderly non-small cell lung cancer.]Tianqing Chu, Jie Shen, Runbo Zhong, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 14, 2011
[Multivariate survival analysis of patients with stage I NSCLC]Jun Pei, Baohui Han, Jie Zhang, et al.
Annals of Translational Medicine|November 9, 2019
Application of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymphangiomaRunbo Zhong, Xiaoxuan Zheng, Jiajun Teng, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 19, 2011
[The clinical analysis of paclitaxel at two dose levels plus carboplatin as the first-line treatment in advanced non-small cell lung cancer]Jialin Qian, Jie Shen, Hao Bai, et al.
Pageof 43

Showing results (31-40 of 426) with videos related to

Sort By:
Pageof 43
International Journal of Clinical and Experimental Pathology|January 23, 2020
Accuracy and clinical influence of plasma EGFR mutation detection in management of advanced lung adenocarcinomaMeili Ma, Chunlei Shi, Jialin Qian, et al.
Thoracic Cancer|September 19, 2017
Lung cancer and benign lung diseases in patients with serious vitamin D deficiency in eastern ChinaRong Li, Jing Wu, Liwen Xiong, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 21, 2025
[Expert Consensus on Diagnosis and Treatment of NSCLC with MET Abnormalities 
(2025 Version)]Jun Chen, Baohui Han, Yi Hu, et al.
Oncotargets and Therapy|April 27, 2018
Efficacy of pemetrexed-based regimens in advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic reviewBaoHui Han, LuLu Yang, Xin Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 8, 2014
MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancerJun Pei, Yuqing Lou, Runbo Zhong, et al.
Journal of Comparative Effectiveness Research|December 17, 2024
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from ChinaHua Zhong, Jun Lu, Mengzhao Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 20, 2010
[The clinical analysis of first-line palitaxel plus platinum-based chemotherapy to treat elderly non-small cell lung cancer.]Tianqing Chu, Jie Shen, Runbo Zhong, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 14, 2011
[Multivariate survival analysis of patients with stage I NSCLC]Jun Pei, Baohui Han, Jie Zhang, et al.
Annals of Translational Medicine|November 9, 2019
Application of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymphangiomaRunbo Zhong, Xiaoxuan Zheng, Jiajun Teng, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 19, 2011
[The clinical analysis of paclitaxel at two dose levels plus carboplatin as the first-line treatment in advanced non-small cell lung cancer]Jialin Qian, Jie Shen, Hao Bai, et al.
Pageof 43